INTRODUCTION
SV40 interacts with cells that are not permissive for viral replication in several ways. In many infected ceils, abortive transformation occurs: the viral T antigens are expressed; synthesis of cellular DNA is stimulated; and a limited number of cell divisions are induced. In a fraction of infected nonpermissive cells, SV40 DNA is inserted into the cellular DNA. If the portion of the integrated viral DNA encoding large T antigen is expressed, the cell becomes stably transformed and continues to exhibit altered growth properties. If the integrated viral DNA is not expressed as functional large T antigen, the cell remains cryptically transformed (1). The integration of viral DNA in both overt and cryptic transformants might be expected on occasion to disrupt cellular genes, either during initial insertion into the host genome or during subsequent rearrangements occurring in SV40-transformed cells (2, 3) . SV40 has been reported to induce chromosome and karyotype abnormalities (4) (5) (6) (7) (8) . Some of these chromosome aberrations may result in inactivation of host genes or other alterations in host gene expression. Specific chromosome aberrations in human cells transfected with origin defective SV40 have been associated with immortitization (9) and tumorigenicity (10) .
Mutations at several different selectable loci have been reported to be induced shortly after SV40 infection of mouse, hamster, and human cells (7, (11) (12) (13) . These mutagenic effects are variable. Investigators have reported no mutagenic effect of SV40 in some experiments and 12-fold or greater increases in the frequency of mutants in other experiments. Conflicting results have been obtained regarding the role of T antigen in SV40-mediated mutagenesis (13, (15) (16) . The underlying mechanism(s) of these mutagenic effects of SV40 is not known. Vogt and Dulbecco (17) proposed the hypothesis that mutagenic effects of papovaviruses may play a role in transformation and tumorigenesis. Our studies were initiated to gain a better understanding of the nature of SV40-induced mutagenesis and the role SV40 mutagenesis might play in T-antigenindependent SV40-mediated cell transformation.
We examined the ability of SV40 to induce mutants resistant to six different selection conditions in a variety of mammalian cells. We found that, in most instances, infection by SV40 does not increase the frequency of mutants above the spontaneous frequency seen in uninfected cells. We have, however, detected two noteworthy instances of SV40-induced drug resistance: one appears to represent an epigenetic phenomenon and the other to be the result of whole chromosome loss. In the first case, infection with SV40 produced a striking induction of Balb/c 3T3 cells resistant to the pyrimidine analogs 5-bromodeoxyuridine (BrdU) and trittuorothymidine (TFT). The second instance of SV40 mutagenesis was noted when interspecific hybrid cells infected with SV40 were observed to lose two distinct human X chromosome loci coordinately. Instability of the BrdU~FT-resistant mutants suggests that on occasion SV40 may induce epigenetic events that confer drug resistance. The coordinate loss of two selectable markers on the same human chromosome from the hybrid cells indicates that SV40 may induce whole chromosome loss.
MATERIALS AND METHODS
Cells. The origins of the untransformed heteroploid Balb/c 3T3 cells (Bc3T3) and BSC-1 cells have been described elsewhere (18, 19) . CHEF/t8 cells are normal diploid Chinese hamster cells (20) . LMTK-APRTcells are chemically transformed heteroploid mouse strain L cells (21) (22) (23) resistant to BrdU (24, 25) and diaminopurine (26) . tsCIAG ~ is a heat-sensitive, azaguanineresistant mutant derived from mouse L cells (27) . The 462-10 near-diploid spontaneously transformed Chinese hamster cells (28) are resistant to BrdU and deficient in thymidine kinase (TK-). CHO-K1 (CCL61) neardiploid spontaneously transformed Chinese hamster cells were obtained from the American Type Culture Collection (12301 Parklawn Dr., Rockwille, Maryland 20852). The origin and characteristics of 157BnpT-1, a heteroploid mouse-human hybrid cell line (tsCIAG a X GM126), have been described (29) . 157BnpT-1B is a subclone of 157BnpT-1, and BSC-1E is a subctone of BSC-1. Cells were grown in 5 ml/25 cm 2 c~-MEM supplemented with 10% fetal or calf bovine serum and were equilibrated with 5% CO2 in air.
Virus. SV40 strain 776 (18, 19) was propagated on BSC-1 or BSC-1E cells at a multiplicity of infection of 1.0-2-10 3 plaqueforming units (PFU) per cell to obtain a crude cell lysate that was concentrated by either: polyethylene glycol precipitation (30); pH 5.6 precipitation (Course Manual: Animal Virus Course, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, H. Diggelmann and P. Beard, pp. [5] [6] 1976) ; or a modification of the pH 5.6 procedure. The modified pH 5.6 procedure was as follows: (1) When approximately 90% of the cells exhibited typical SV40 CPE, the cultures were frozen and thawed three times and the debris collected by scraping with a rubber policeman into medium containing 2% fetal bovine serum (FBS). (2) The medium was acidified by adding 1/50 to 1/100 vol of 2 M KNa2PO 4 pH 5.6. (3) The acidified crude lysate was incubated overnight at 4°C. (4) Virus was pelleted by centrifugation at 8000g for 40 min at 4°C and resuspended in 1/40 volume of medium with 2% FBS. (5) The concentration of NaHCO 3 was adjusted to 50 mM with 7.5% NaHCO 3 and the virus suspension was stirred overnight at 4°C. (6) The resuspended virus concentrate was sonicated at full power using a Heat Systems model W375 with a 431A cup horn for 3 min at room temperature. (7) The sonicated virus concentrate was centrifuged at 8000g for 10 min at 37°C. The supernatant was collected and saved and the pellet resuspended in medium with 2% FBS and 50 mM NaHCO3 (half the volume of the step 6 virus concentrate), sonicated, and centrifuged as described. The second supernatant was added to the first step 7 supernatant. Virus concentrates produced by this procedure yielded titers ranging from 1.7 to 9.5 x 101° PFU/ml. Mock-infected BSC-1 cells were frozen and thawed three times in medium with 2% fetal bovine serum to produce a mock lysate. A mock lysate processed by the modified pH 5.6 procedure gave rise to the mock lysate concentrate.
Infection Protocol. Medium was removed from monolayers, and virus was added at a multiplicity of infection ranging from 102 to 8 × 104 in a volume of 0.2-.3.0 ml/25 cm 2 for 2-5 h. After infection, growth medium was added without removing unabsorbed virus.
Drug Selection Systems. Drug selection systems used were: 6-thioguanine (6TG, 25 ixg/ml) for loss of hypoxanthine-guanine phosphoribosyltransferase (HPRT); BrdU (30 l~g/ml) and TFT (1 ~g/ml) were used in combination for stringent selection for loss of TK; and cytosine arabinoside (araC, 1 txg/ml) for loss of deoxycytidine kinase (dCK). HAT medium (hypoxanthine, 10 .4 M; aminopterin, 4 x 10 .7 M ; and thymidine, 1.6 x 10 -5 M) was used to select for TK + cells. Colonies were stained with Wright's stain.
Temperature Selection. tsCIAG R cells and 157BnpT-1 mouse-human hybrids that lack the heat-resistance locus hrCl (CIHR, Human Gene Mapping Conference, 31) located on the human X chromosome are killed at the nonpermissive temperature (npT) of 38.5°C, but grow at the permissive temperature (pT) of 34°C (29) . 157BnpT-1 and derivatives that have the human X chromosome grow at both the permissive temperature and nonpermissive temperature, as do heat-resistant revertants of tsCIAG R. Hybrids that grow in TG at the nonpermissive temperature represent presumptive X chromosome rearrangement events or mutation at the HPRT locus. Hybrids that grow in 6TG at the permissive temperature and are heat sensitive without selection for loss of the hrCl locus represent presumptive human X chromosome loss events.
Chromosome Loss Test.
To test for whole chromosome loss, mouse-human hybrid cells grown under selective conditions to fix the human X chromosome markers are shifted to nonselective conditions and exposed to the test agent for a specific time (time of treatment). The time of treatment was typically five days for virus, cotchicine, or colcemid. After treatment, the cells are grown under nonselective conditions in the absence of the test agent for a specific time (time of expression) to permit the phenotypic expression of any mutations induced during the treatment period. After the expression period, the cells are selected in 6TG at the permissive temperature or nonpermissive temperature for a period of approximately 10 days to two weeks and the frequency of colony-forming cells (CFC) is determined at the permissive temperature and nonpermissive temperature. Treatment controls consist of cells treated with medium, with a drug known to induce chromosome loss such as colchicine or colcemid (32) (33) (34) , or with a mock lysate. Strong presumptive evidence for whole human X chromosome loss is that the frequency of CFC in 6TG permissivetemperature test cultures is greater than the frequency of CFC in 6TG permissivetemperature control cultures and that the frequency of 6TG-resistant cells that are heat sensitive in the test cultures is greater than the frequency of 6TG resistant cells that are heat sensitive in the control cultures. Strong evidence for human X chromosome rearrangement or mutagenesis at the structural gene locus of human HPRT is that the frequency of CFC in 6TG nonpermissivetemperature test cultures is greater than the frequency of CFC in 6TG nonpermissivetemperature control cultures.
T-Antigen Staining. T-antigen-positive
cells grown on glass slides were visualized by indirect immunofluorescence assay (IFA) using anti-SV40 hamster antiserum (Office of Program Resources and Logistics, National Cancer Institute) and fluorescein isothiocyanate-conjugated goat or rabbit antihamster serum after fixation in acetone at -20°C.
TKAssay. Cells from three 15-cm tissue culture dishes were harvested, resuspended in 0.5 ml of extraction buffer (10 mM KC1, 1 mM MgCI 2, 50 lxM thymidine, 3 mM [3-mercaptoethanol, and 10 mM Tris HC1, pH 8.0), frozen and thawed four times, and centrifuged in a Beckman microfuge at approximately 10,000 g for 20 rain at 4°C. The supernatant was collected and stored at -70°C prior to assay as described (35) . Protein was assayed by the method of Lowry et al. (36) . TK activity was expressed as the counts per minute per microgram protein per 30 min relative to Bc3T3 (100%).
[3H]BrdU Uptake. Cells were seeded into 24-well plates at 104 cells/well in growth medium and incubated for 24-48 h at 37°C. The cells, at approximately 50% confluency, were labeled with [3H]BrdU 1 lxCi/ml in o~-MEM with 1% fetal calf serum at 37°C. Duplicate wells were rinsed three times with phosphate-buffered saline, and the cells were lysed by the addition of 0.25 ml of 10 mM EDTA plus 0.6% SDS (sodium dodecytsulfate). 1Ne lysate was removed and acid precipitable radioactivity was determined by spotting 0.2 ml of lysate onto a Whatman GF/B filter previously soaked in 5% TCA. The filter was rinsed extensively with 5% TCA, 95% ethanol, dried, and counted in nonaqueous scintillation fluid. Autoradiography. Cells were grown in 1.6-cm 2 wells as described above and labeled for 10-24 h with 1 ~zCi/ml of [3H]BrdU. The medium was removed and the cells washed twice with PBS. The cells were fixed with 100% ethanol-glacial acetic acid (3:1, v/v) for 5 min followed by 5% TCA for 5 rain. The cells were washed three times in 70% ethanol and once with 100% ethanol for 10 min each. Each well was coated with Kodak NTB2 emulsion and exposed in a lightproof box kept at 4°C for five days. The emulsion was developed with Kodak D-19 developer, fixed, and the cells were examined using phasecontrast microscopy.
RESULTS

Expression of T Antigen. Effects of SV40
were assessed in transformed and untransformed cells that are either diploid, near diploid, or heteroploid (Table 1) . T-antigen staining was done to determine the infectability of target cells, which should directly affect the frequency of cells subject to SV40 mutagenic effects. This assay depends on the ability of infected cells to express the early genes of SV40 as well as to take up and uncoat SV40 virions. The presence of detectable T antigen varied considerably among the various cell lines (Table 1) . Spontane- ° The frequency of T-antigen-positive cells was determined by IFA five to six days after infection at an MOI of 104.
ously transformed Chinese hamster cell lines and chemically transformed mouse L cell lines expressed little or no T antigen. The low level of T antigen expression in mouse L cells may be due to reduced uptake of SV40, since SV40 uptake by L M T K cells is approximately 500-fold less efficient than uptake by primary monkey cells and approximately 120-fold less efficient than uptake by CV-1 cells (37) . Untransformed Chinese hamster cells exhibited a moderate frequency of T-antigen-positive cells, while the untransformed mouse Bc3T3 cells had a high frequency of T-antigen-positive cells. The mouse-human hybrid cell line exhibited a very high frequency of T-antigen-positive cells. The hybrid contained human chromosomes 3, 14, X, and possibly chromosome 15 in addition to approximately twice the number of mouse chromosomes found in tsC1 cells. It is possible that the human chromosomes present in the hybrid enable these cells to either take up, uncoat, or express SV40 more efficiently than the parental mouse cells.
Effect of SV40 on Drug or Temperature
Resistance in CHOK1, 462-10, LMTK-, tsC1, and CHEF Cells. We did not observe SV40 induction of CHOK1 mutants resistant to araC (Table 2) . A small increase in the frequency of 6TG-resistant cells was noted in CHOK1 cells, but the significance of this increase is questionable due to the fact that the fractional error was high in both the control and the infected cultures. The 462-10 Chinese hamster cells exhibited a modest increase in the frequency of araC-resistant cells after infection with SV40 (Table 2) . When SV40-infected 462-10 cells were treated with a low concentration of colcemid to promote chromosome loss and uncover recessive mutations, the frequency of araCresistant cells was increased several-fold relative to the medium and mock lysate controls and the culture treated with SV40 alone. These results suggest that SV40 may induce recessive mutations or cryptic mutagenic events that may be uncovered by chromosome loss. When SV40-infected 462-10 cells were selected for resistance to 6TG, a small increase was noted when the infected cells were treated with colcemid. The high background frequency of 6TG-resistant cells in 462-10 limits the sensitivity of this test system.
We examined LMTK-for forward muta- t~ tion to 6TG resistance after infection and failed to detect any 6TG-resistant mutants, although a reconstruction experiment using a defined mixture of 6TG-resistant tsC1 cells and 6TG-sensitive LMTK-cells demonstrated that 6TG resistant mutants should have been recoverable under the conditions of this experiment (data not shown). We tested heat-sensitive tsC1 mouse cells for the presence of mutants resistant to heat after infection. SV40 did not enhance the frequency of heat-resistant revertants ( Table 2) . CHEF cells express a moderate level of SV40 T antigen in contrast to CHOK1, 462-10, LMTK-, and tsC1, which express only low levels of T antigen. Three experiments with CHEF cells (Table 2) produced no evidence for SV40-induced resistance to 6TG. One infection of CHEF cells at a high multiplicity of infection yielded five 6TG-resistant clones, none of which expressed SV40 T antigen detectable by IFA or immunoprecipitation PAGE analysis.
Induction of Resistance to Thymidine Analogs in SV40-Infected Bc3T3 Cells. The
Bc3T3 line of mouse cells is readily infected by SV40. Transformation of Bc3T3 cells has been studied extensively (2, 19) and occurs at a frequency of 10 -5 transformants/PFU. Integration of SV40 DNA in Bc3T3 cells occurs at a high frequency (1). After infection with SV40, the majority of Bc3T3 cells also express T antigen (Table 1) . One of three plates of SV40 infected Bc3T3 cells selected for resistance to BrdU + TFT (presumptive TK-) yielded one very large colony and several small colonies that may have been satellite colonies. A number of these BrdU + TFT (BT) -resistant colonies were picked and maintained as independent cell clones (9C series). All nine clones tested were positive for T-antigen expression. When 9C clones were plated in HAT medium, which selects for TK + cells, HAT-resistant cultures readily became established in a single passage. Subclones isolated from 9C primary clones in BT medium exhibited a high frequency of HAT-resistant cells (10 3_ 104) , which suggests that the drug-resistance phenotype is unstable. Infection of Bc3T3 cells at a higher multiplicity of infection (8. (Table 3) . Two SV40-transformed lines, not selected for drug resistance, had levels of [3H]BrdU uptake of 80% and 130% relative to Bc3T3 cells (Table 3) , which demonstrated that the reduction of BrdU uptake in the BT-resistant cells was not a simple consequence of SV40 infection, T-antigen expression, or SV40-mediated transformation. The uptake of [3H]thymidine was measured and was found to be proportional cells. An SV40-transformed cell line not selected for drug resistance possessed 76% of wild-type Bc3T3 TK activity, while L M T K cells, a thoroughly studied stable mutant cell line deficient in TK, expressed only 1% of the Bc3T3 level of TK. Mammalian cells take up thymidine via two systems: a low-affinity nonconcentrative facilitated diffusion process that is a general pathway for nucleoside uptake (38, 39) and a high-affinity concentrative process dependent on the presence and specific type of TK expressed in the mammalian cell (39) . The difference observed in BrdU uptake between BT-resistant ceils and Bc3T3 at low substrate concentration probably reflects a difference in the TK-dependent high-affinity system, which suggests that the key defect in BT-resistant cells is a loss of TK activity that both prevents BrdU and TFT incorporation and reduces BrdU (and probably TFT) uptake.
Autoradiography was performed on cell monolayers of BT-resistant cells and Bc3T3 cells exposed to medium containing [3H]BrdU. The nuclei in the Bc3T3 monolayers were uniformly heavily labeled, while the majority of cell nuclei in the BT-resistant cell monolayers were unlabeled. However, the BT-resistant cell lines exhibited a background of heavily labeled cell nuclei. The 9C-4-1 and 9C-5-3 subclones had 15% and 24% heavily labeled nuclei, while 68B1 and 68B3 had 2.2% and 0.6% heavily labeled nuclei, respectively. The results of the autoradiography experiments are consistent with the TK activity and BrdU uptake observations and indicate that the small amount of residual TK activity and BrdU uptake is due to a small fraction of cells with near-normal phenotype rather than a uniform low level of TK activity in all cells. Since the drugresistance phenotype is relatively unstable and cloned cell populations (9C series) are heterogeneous in phenotype, the drugresistant cells may not be mutants at the level of DNA sequence but may be due to an epigenetic phenotype switching event induced by SV40 infection.
Effect of SV40 Infection on Thioguanine Resistance in Mouse-Human Hybrid Cells. To test for SV40-induced chromosome loss or chromosome rearrangement, we examined the frequency of thioguanine-resistant cells in SV40-infected 157BnpT-1B cells that express high levels of SV40 T antigen after infection. These hybrid cells have two selectable markers on the human X chromosome: HPRT, which confers sensitivity to 6TG and resistance to HAT medium, and C1HR, a locus which confers resistance to 38.5°C, which is the nonpermissive temperature of the heat-sensitive mutant mouse cell used to construct the hybrid. These two selectable markers on the same chromosome permit a direct test for whole chromosome loss induced by any potentially clastogenic agent, since loss of the whole human X chromosome results in a cell that is simultaneously 6TG resistant, HAT sensitive, and temperature sensitive.
SV40-infected hybrid cells that survive 6TG selection may have undergone any of a number of mutagenic events capable of conferring resistance to 6TG, such as whole X chromosome loss, breakage or rearrangement of the X chromosome followed by loss or inactivation of the HPRT locus located in the distal long arm of the human X chromosome, insertional inactivation of the HPRT locus by SV40, or other mutagenic event (base substitution, deletion, etc.) in the structural or regulatory region of the HPRT locus. It is assumed that the probability of simultaneous structural gene mutations at two loci is low compared to the probability of whole chromosome loss. Interspecific mouse-human hybrids generally exhibit preferential loss of human chromosomes at a rate substantially higher than the spontaneous frequency of 6TG-resistant mutants in mammalian cells (40) (41) (42) .
SV40-infected hybrid cells were tested for the frequency of 6TG-resistant cells at 33°C seven days after treatment at 33°C with a mock cell lysate, cotchicine at 0.015 p~gjmI for five days, or SV40 at multiplicities of infection of 1700, 5200, or 15,000 for five days. Cells treated with colchicine, an agent known to induce chromosome loss, exhibited a 7.8-fold increase in the frequency of 6TG-resistant cells relative to the mock lysate control, while cells infected with SV40 at the highest multiplicity of infection showed a 3.5-fold increase ( Table 2 ). The effect of SV40 infection on the frequency of 6TG-resistant hybrid cells appeared to be proportional to the multiplicity of infection, since only a marginal increase was noted at an intermediate multiplicity of infection and no effect was observed at the lowest multiplicity of infection.
To determine whether the increase in 6TG-resistant cells represented chromosome loss, an experiment was performed in which the frequency of 6TG-resistant cells was determined at the permissive temperature and at the nonpermissive temperature. In this experiment, colcemid was used instead of colchicine. Colcemid produced a dramatic 56-fotd increase in the frequency of 6TG-resistant cells at the permissive temperature. Greater than 99% of the colcemid-induced 6TG-resistant hybrids were heat sensitive, which demonstrated that the 6TG-resistant cells lacked both the HPRT and C1HR loci and probably arose through colcemidinduced loss of the human X chromosome. SV40 infection produced a 12.7-fold increase in the frequency of 6TG-resistant hybrids at the permissive temperature and a 2.8-fold increase in the frequency of 6TG-resistant hybrids at the nonpermissive temperature.
These observations indicated that most of the 6TG-resistant mutants induced by SV40 probably represented human X chromosome loss events because 80% of the 6TG-resistant hybrids have also lost the X-linked heatresistance locus C1HR. Twenty percent of the SV40-treated 6TG-resistant hybrids have the C1HR locus and represent X chromosome rearrangement events or mutagenesis at the HPRT locus.
DISCUSSION
We found SV40 to be nonmutagenic or weakly mutagenic in cell lines expressing T antigen at levels ranging from undetectable to moderate. The lack of ability to detect mutagenic effects may be due to: the ability of the host cell to absorb, internalize, and uncoat virions; host cell effects on virus gene expression; host cell response to viral gene products; the linkage arrangement of nonessential selectable genes with respect to essential genes; metabolic cooperation and cell density at selection; and gene copy number of loci subjected to selection (43, 44) . The modest mutagenic effects of SV40 noted by others are probably not significantly different from the small increases we observed in the frequency of 6TG-resistant cells in SV40-infected cultures of CHOK1, 462-10, or CHEF.
The cell lines in our study that had the highest infection rates, Bc3T3 and the mouse-human hybrid, exhibited the most significant levels of induced drug-resistant cells (viz. 10-3-10-4 Epigenetic Effects of SV40. Epigenetic effects of SV40 on host ceil gene expression have been described by Soprano et al. (48) , who noted an SV40 T antigen-dependent activation of human rDNA genes in mousehuman hybrid cells. Parker et al. (49) found that the alpha 2(1) procollagen gene was transcriptionally inactivated in SV40-transformed WI38 cells but was active in normal WI38. Matsumura et al. (50, 51) reported that human diploid fibroblasts exhibit declining levels of methylation during passage but that methylation levels are maintained in SV40-transformed precrisis human diploid fibroblasts. During the course of studies investigating the possible role of methylation in inactivation of tumor suppressor genes, de Bustros et al. (52) discovered that SV40-infected human cells exhibit altered methytation in the region of the calcitonin gene. Epigenetic effects of SV40 on the host cell genome may play a role in mediating SV40-induced cell transformation.
Clastogenic Effects of SV40. We exploited the properties of a hybrid cell line that contains a human X chromosome carrying two selectable markers on a mouse L-cell background. The human X chromosome is dispensable when the hybrid cells are grown under nonselective conditions, which permits these cells to be used to test for clastogenic agents using X-linked selective markers. In contrast, whole X chromosome loss in CHOK1, 462-10, and CHEF is likely to be lethal, and these cell lines are not suitable for testing virus-induced whole chromosome loss using selectable X-linked markers.
When the hybrids were treated with low concentrations of a drug known to produce whole chromosome loss or nondisjunction, a substantial increase in the frequency of 6TG-resistant heat-sensitive cells was observed, which is indicative of whole chromosome toss. After SV40 infection, the hybrid cells also exhibited an increase in human X chromosome loss, albeit not as great as the loss produced by colcemid treatment. This clastogenic effect of SV40 could mimic various classical chemical mutagens such as ethyl methane sulfonate by uncovering preexisting recessive mutations in heteroploid cultured cells. Ornitz et al. (53) described two stages in the development of SV40-induced pancreatic adenocarcinoma in transgenic mice: an initial preneoplastic stage, in which T antigen is expressed and morphological progression occurs from hyperplasia to dysplasia, and a second stage characterized by tumor nodules with aneuploid DNA contents. These investigators suggest that the transformation events that they observed may occur coincidently with chromosome loss.
SUMMARY
Our results demonstrate that SV40 may induce whole chromosome toss in addition to the well-known ability of SV40 to induce chromosome rearrangements and structural abnormalities. Our observation of SV40-induced unstable TK-mutants in Bc3T3 cells demonstrates a new epigenetic effect of SV40 infection on the cell phenotype. The extent of SV40 epigenetic effects on host cell transformation remains to be elucidated. In view of the ubiquitious presence of papovaviruses related to SV40 in the human population (54, 55) it may be of interest to determine if other papovaviruses are capable of inducing similar effects.
